Search for: "TAP PHARMACEUTICAL PRODUCTS, INC" Results 1 - 20 of 47
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Mar 2024, 7:24 pm by Kurt R. Karst
Namely, Biogen MA Inc. must demonstrate its agency relationship with the NDA holder (Biogen, Inc.) as it relates to the approved product and provide evidence of its express authorization to rely upon the regulatory activities by Biogen, Inc. [read post]
19 Nov 2021, 7:47 am by Cinthia Macie
  Kirin owns a wide array of brands globally, as well as firms in other industries such as pharmaceuticals, real estate, and agricultural biosciences. [read post]
11 Nov 2021, 2:07 pm by Kevin LaCroix
    Record-Setting Equity Markets and Low Litigation Rates During 3Q of 2021 and 4Q’s kick-off, liquidity permeates the capital markets leading public corporations trading in the U.S. markets to reach $50 trillion in aggregate market capitalization.[12] This is about $20 trillion more than one year ago (~67% increase in market cap during a global pandemic…) and the Federal Reserve is reluctant to restrict the money supply by keeping the federal funds rate at 0.25% while… [read post]
6 Feb 2019, 4:27 am
This was summarised by HHJ Hacon as a "basic principle of patent law in the United Kingdom" and cited Merrell Dow Pharmaceutical Inc v H. [read post]
23 Jan 2019, 6:12 pm by Stan Gibson
In a patent infringement action, Takeda Pharmaceuticals America, Inc., and Takeda Pharmaceuticals U.S.A., Inc. [read post]
26 Sep 2017, 2:15 pm by Tom Lamb
The drug is Intercept’s only commercial product and was approved in the U.S. in May last year. [read post]
6 May 2016, 12:30 pm
Tap Pharmaceuticals, Inc., 2004 WL 2550593, at *5 (W.D. [read post]
30 May 2014, 6:00 am by Tom Lamb
PTC/IIH Symptoms Include Migraines With Blurred Or Double Vision, Temporary Blindness, Other Visual Problems, And Wooshing Or Ringing In The Ear (Posted by Tom Lamb at DrugInjuryWatch.com)Mirena is an intrauterine system (IUS) from Bayer Healthcare Pharmaceuticals, Inc. that releases 20 μg/day of levonorgestrel. [read post]
31 Dec 2012, 11:41 pm by Shouvik Kumar Guha
Next in line is a guest post by Madhulika Vishwanathan in the Spicy IP Fellowship Post Series, wherein she has referred to few landmark judgments in 2012 pertaining to the Indian pharmaceutical patent industry, including the grant of compulsory license to Natco Pharma, revocation of the Sunitinib patent owned by Pfizer/Sugen, the Roche-Cipla patent infringement suit, revocation of India’s first pharmaceutical product patent etc. [read post]
7 Sep 2012, 3:23 pm by Bexis
Allergan USA, Inc., 2012 WL 3692396 (E.D. [read post]